Across TCGA pan-cancer cohorts, MTND1P34 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MTND1P34’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MTND1P34 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MTND1P34 is over-expressed in tumor.

STAD and BRCA are the cancer types where MTND1P34 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTND1P34 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	+0.181	.002	6	view →
BRCA	All	All	+0.109	.025	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MTND1P34 RNA expression & survival · all MTND1P34 data types